CONCLUSIONAn effective polymer selection criterion was identified and the identified polymer showed a high capacity to absorb both phenol and butyl acetate. Both substrates were successfully degraded in solid-liquid TPPBs using the selected polymer and using mixtures of waste polymers. (c) 2013 Society of Chemical Industry”
“Filamentation
in an argon plasma is studied Acadesine datasheet using a microwave cavity at atmospheric pressure. We show that the size and gas temperature of the filaments increase with the power absorbed by the plasma. The appearance of an additional filament occurs at specific values of the absorbed power. Each new filament appears with a smaller diameter than that of its parent filament but the sum of the diameters of all filaments evolves linearly with the absorbed power. A secondary filament emerges from a set of microfilaments created by a perturbation of the electric field (a slight increase in the incident power above a threshold value). This perturbation occurs LY333531 price over a larger radius than that of the parent filament. By resorting to modeling, we found that the filamentation process involves either a decrease in the effective frequency for momentum-transfer collisions, i.e.,
a lower electron temperature, or an increase in the electron density. We could show that a small change in the relative positions occupied by two filaments in the microwave cavity requires a strong variation in the electron temperature. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3125525]“
“Background: Iron is an indispensable element of hemoglobin, myoglobin, and cytochromes, and, beyond erythropoiesis, is involved in oxidative metabolism and cellular Go6983 manufacturer energetics. Hence, iron deficiency (ID) is anticipated to limit exercise capacity. We investigated whether ID predicted
exercise intolerance in patients with systolic chronic heart failure (CHF).
Methods and Results: We prospectively studied 443 patients with stable systolic CHF (age 54 +/- 10 years, males 90%, ejection fraction 26 +/- 7%, New York Heart Association Class I/II/III/IV 49/188/180/26). ID was defined as: serum ferritin <100 mu g/L or serum ferritin 100-300 mu g/L with serum transferrin saturation <20%. Exercise capacity was expressed as peak oxygen consumption (VO2) and ventilatory response to exercise (VE-VCO2 slope). ID was present in 35 +/- 4% (+/-95% confidence interval) of patients with systolic CHF. Those with ID had reduced peak VO2 and increased VE-VCO2 slope as compared to subjects without ID (peak VO2: 13.3 +/- 4.0 versus 15.3 +/- 4.5 mL.min.kg, VE-VCO2 slope: 50.9 +/- 15.8 versus 43.1 +/- 11.1, respectively, both P < .001, P < .05). In multivariable models, the presence of ID was associated with reduced peak VO2 (beta = 0.14, P < .01 P < .05) and higher VE-VCO2 slope (beta = 0.14, P < .01 P < .